In honour of #ParkinsonsAwarenessMonth, I would like to introduce RAPSODI - an online study recruiting close blood relatives (parents, brothers/sisters, children) of #GaucherDisease patients to develop life changing treatments for Parkinson's Disease: rapsodistudy.com/en

Today is #WorldParkinsonsDay! A groundbreaking trial exploring cough medicine as a new treatment for Parkinson’s disease is being led by UCL and Prof Tony Schapira (UCL Queen Square Institute of Neurology). Learn more about it here ⬇️ bit.ly/3mde79f

#ParkinsonsAwarenessMonth is well underway, and we are working hard to raise awareness about Parkinson’s disease during April! If you are diagnosed with PD and would like to get involved in trials, join PDFrontline🧬 today at pdfrontline.com/en #GetTrialReady

This #ParkinsonsAwarenessMonth, we are proud to celebrate the ASPro-PD trial - a large phase 3 trial to determine whether the drug Ambroxol can slow the progression of Parkinson's disease, which will begin recruitment later this year. Find out more here: rapsodistudy.com/en/ambroxol

As we approach the mid point of the year, we are excited to share our newsletter: "Spring into Action 2023", the progress of PD Research and a piece about mental health in Parkinson's Disease! Read all about it here: drive.google.com/file/d/1ybMCQC…

Read our new newsletter about the RAPSODI study, recent advances in Parkinson's research and ways to get involved here: drive.google.com/file/d/1QtbVzy…

Exciting new work on GBA1 variant carriers with and without Parkinson disease (RAPSODI), delighted to have helped ⁦marcotoffoli⁩ in ⁦Tony Schapira⁩ ⁦Aligning Science Across Parkinson’s⁩ team medrxiv.org/content/10.110…

Our letter Investigating sex specific differences in GBA1 carriers with LBD is out in Movement Disorders now: …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…

Last week, we spent an exciting two days discussing our latest data and new ideas with our researchers from our centres in the UK, France, Germany and Italy as part of Aligning Science Across Parkinson’s

New research from Tony Schapira & RAPSODI colleagues shares phenotypic effect of GBA1 variants in individuals with & without #Parkinsons; N=379 (89 GBA1-neg. controls, 169 GBA1-neg. PD, 47 GBA1-pos. PD, 47 non-affected GBA1 carriers, 27 Gauchers) sciencedirect.com/science/articl…

New research from Tony Schapira & colleagues supports a mechanism by which exposure of enteroendocrine cells to specific bacterial factors found in #Parkinsons gut dysbiosis might facilitate accumulation of α-synuclein pathology in the gut academic.oup.com/braincomms/art…

Earlier this week, researchers from our Aligning Science Across Parkinson’s teams across the UK came together in London to discuss new data and ideas, and hear from our Early Career Researchers and their latest findings in Parkinson Research

I want to thank everyone on RAPSODI and PDFrontline🧬 very much for your contributions to the field of Parkinson research. We are only able to move forward with our research with your help and participation. Wishing everyone happy holidays and a good start to the new year!

It was a pleasure to give the Dorothy Russell Memorial Lecture at the British Neuropathological Society BNS Neuropathology Meeting last month, discussing Parkinson Disease and the gut-brain axis

Welcome to our newest team members, Georgie and Milly! Georgie has recently finished her BSc in Biomedicine, and Milly is a Biology and Chemistry MSc Graduate. Both will be working on the PDFrontline🧬 study and other ongoing studies within our team🧠

Our latest review on Pharmacomicrobiomics and potential application of gut microbiota based interventions in Parkinson disease! Food for thought... link.springer.com/article/10.100…

Today is #WorldParkinsonsDay 2024 🌎I would like to take this opportunity to thank all of our participants on the Ext and PDFrontline🧬 studies who are enabling us to conduct important research into the role of the GBA gene in Parkinson's Disease🧠

Yesterday, Georgie and Milly presented PDFrontline🧬 at the Cure Parkinson's Spring Research Update – “We had a great time talking to some of our participants and listening to interesting research opportunities and updates from leading researchers in the field."